A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

NCT02512575 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Pharmacokinetics
Pharmacodynamics
Healthy Subjects
Rheumatoid Arthritis

Interventions

DRUG: AZD9567 Monohydrat
DRUG: Placebo oral suspension/ Placebo capsule
DRUG: Prednisolone

Sponsor

AstraZeneca